These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30632893)

  • 21. The autoimmune ecology: an update.
    Anaya JM; Restrepo-Jiménez P; Ramírez-Santana C
    Curr Opin Rheumatol; 2018 Jul; 30(4):350-360. PubMed ID: 29438164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interleukin 2 revival: a revisited model and new therapeutic applications].
    Jacques Y; Mortier E
    Med Sci (Paris); 2016; 32(6-7):612-8. PubMed ID: 27406772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
    Zhong Z; Sanchez-Lopez E; Karin M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Simultaneous determination of the level of immune complexes and immunoglobulins for characterization of the pathologic process].
    Vel'bri SK; Lilleorg AL; Lindstrem SL
    Lab Delo; 1988; (5):7-11. PubMed ID: 2459464
    [No Abstract]   [Full Text] [Related]  

  • 25. Pro-inflammatory and pathogenic properties of Annexin-A1: the whole is greater than the sum of its parts.
    D'Acquisto F; Piras G; Rattazzi L
    Biochem Pharmacol; 2013 May; 85(9):1213-8. PubMed ID: 23435354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Untapped Opportunity and Challenge of Immunometabolism: A New Paradigm for Drug Discovery.
    Mazumdar C; Driggers EM; Turka LA
    Cell Metab; 2020 Jan; 31(1):26-34. PubMed ID: 31839485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review).
    Zhang Q; Ding S; Zhang H
    Mol Med Rep; 2017 Nov; 16(5):6472-6482. PubMed ID: 28901492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases.
    Pandolfi F; Cianci R; Casciano F; Pagliari D; De Pasquale T; Landolfi R; Di Sante G; Kurnick JT; Ria F
    J Biol Regul Homeost Agents; 2011; 25(2):153-61. PubMed ID: 21880203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between myeloid-derived suppressor cells and S100A8/A9 in tumor and autoimmune diseases.
    Zheng R; Chen S; Chen S
    Int Immunopharmacol; 2015 Dec; 29(2):919-925. PubMed ID: 26508452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of metabolomics in autoimmune diseases: insight into biomarkers and pathology.
    Kang J; Zhu L; Lu J; Zhang X
    J Neuroimmunol; 2015 Feb; 279():25-32. PubMed ID: 25669996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current understanding on the immunological functions of tumor necrosis factor-related apoptosis-inducing ligand.
    Wei W; Liu Y; Zheng D
    Cell Mol Immunol; 2005 Aug; 2(4):265-9. PubMed ID: 16274624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease.
    Yasunaga M; Manabe S; Matsumura Y
    Sci Rep; 2017 Sep; 7(1):10735. PubMed ID: 28878234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The frontline of immune response in peripheral blood.
    Song F; Qian Y; Peng X; Li X; Xing P; Ye D; Lei H
    PLoS One; 2017; 12(8):e0182294. PubMed ID: 28771541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamers in immunological research.
    Nezlin R
    Immunol Lett; 2014 Dec; 162(2 Pt B):252-5. PubMed ID: 25447403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocytes in Inflammation, Resolution of Inflammation, Autoimmune Diseases and Cancer.
    Filep JG
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quid pro Quo: A Tumor is Not Alone.
    Sacristán C; Tuveson DA
    Trends Mol Med; 2017 May; 23(5):375-376. PubMed ID: 28408271
    [No Abstract]   [Full Text] [Related]  

  • 38. The P2X7 receptor: A main player in inflammation.
    Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
    Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases.
    Pereira R; Faria R; Lago P; Torres T
    Curr Drug Saf; 2017; 12(3):162-170. PubMed ID: 28625143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cells, leptin and angiogenesis.
    Pucino V; De Rosa V; Procaccini C; Matarese G
    Chem Immunol Allergy; 2014; 99():155-69. PubMed ID: 24217608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.